SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-070768
Filing Date
2024-03-19
Accepted
2024-03-19 07:41:02
Documents
15
Period of Report
2024-03-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d768236d8k.htm   iXBRL 8-K 28487
2 EX-99.1 d768236dex991.htm EX-99.1 8841
6 GRAPHIC g768236g0319061252300.jpg GRAPHIC 5361
  Complete submission text file 0001193125-24-070768.txt   175962

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgen-20240318.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20240318_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20240318_pre.xml EX-101.PRE 11721
19 EXTRACTED XBRL INSTANCE DOCUMENT d768236d8k_htm.xml XML 3793
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14656 | Film No.: 24761103
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)